TGF-β represses the cytolytic function of effector CD8+ cells by downregulating cytolytic genes (e.g., Fas ligand, perforin, granzyme A, B and IFN-γ) in autoimmune diseases and cancer (Thomas and Massague, 2005). This evidence concerns the gene TGFB1 and cancer.